Some researchers claimed that IL-11-mediated activation of JAK/STAT3 was crucial in gastrointestinal carcinogenesis following LKB1 mutations and that targeting this pathway offers therapeutic potential in PJS (31). Here, IL11 is linked to Peutz-Jeghers syndrome.